Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research • 07/16/24
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US marketReuters • 07/12/24
Novo Nordisk Stock Pops After Weight-Loss Drug Cuts Dementia Risk In Yearlong StudyInvestors Business Daily • 07/12/24
Novo Nordisk receives Complete Response Letter in the US for once-weekly basal insulin icodecGlobeNewsWire • 07/10/24
US Senator Sanders optimistic Novo Nordisk can be pressured to cut Wegovy, Ozempic pricesReuters • 07/10/24
Novo Nordisk shares take a hit after a report revealed Eli Lilly's better weight loss drugFast Company • 07/09/24
Novo Nordisk Falls as Study Says Eli Lilly Weight-Loss Ingredient More EffectiveInvestopedia • 07/09/24
Eli Lilly weight-loss drug found more effective than Novo Nordisk's OzempicProactive Investors • 07/09/24